Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Squaric acid dibutylester effectively treats alopecia areata.

Topical ruxolitinib quickly improves non-segmental vitiligo.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

A patient with complete hair loss regrew all her hair using tofacitinib.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Tofacitinib taken by mouth helps treat hair loss in children.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.